AstraZeneca manufacturing error raises questions about vaccine study results

CBC.ca

26 Nov 2020 0 shares 1 views

AstraZeneca manufacturing error raises questions about vaccine study results

CBC.ca

Published 26 Nov 2020

AstraZeneca and Oxford University on Wednesday acknowledged a manufacturing error that is raising questions about preliminary results of their experimental COVID-19 vaccine.

Full Article

European Shares Rise In Thin Trading

RTTNews 27 Nov 2020

European stocks rose on Friday even as questions were raised about the results of AstraZeneca's late-stage vaccine study,..

AstraZeneca mulls new coronavirus vaccine trial following results confusion
Proactive Investors 27 Nov 2020
DAX Edges Higher Despite Vaccine Worries
RTTNews 27 Nov 2020
AstraZeneca manufacturing error clouds Oxford vaccine study results
Mid-Day 27 Nov 2020
UK asks regulator to assess AZ-Oxford vaccine amid questions
SeattlePI.com 27 Nov 2020

More coverage

Expert sees "nothing sinister" amid questions over vaccine's data

CBS News 26 Nov 2020

AstraZeneca and Oxford University acknowledged a manufacturing error that raised questions about preliminary results of their..

Expert sees "nothing sinister" amid questions over Oxford vaccine trial data
Upworthy 26 Nov 2020
Dosing Mix-up Raises Questions About Promising Covid-19 Vaccine
Upworthy 26 Nov 2020
AstraZeneca Covid vaccine study results clouded by manufacturing error
Upworthy 26 Nov 2020
AstraZeneca admits the best results in its COVID-19 vaccine study came from a dosing error, and experts are raising new questions about the shot
Business Insider 26 Nov 2020

AstraZeneca manufacturing error raises questions about vaccine study results

AstraZeneca manufacturing error raises questions about vaccine study results

You might like

Related news coverage

European Shares Rise In Thin Trading

Advertisement

More coverage

Expert sees "nothing sinister" amid questions over vaccine's data